Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration

12 Jul 2024

Abstract excerpt

Polyglutamine (polyQ) diseases are a group of inherited neurodegenerative disorders caused by expanded cytosine-adenine-guanine (CAG) repeats encoding proteins with abnormally expanded polyglutamine tract. A total of nine polyQ disorders have been identified, including Huntington's disease, six spinocerebellar ataxias, dentatorubral pallidoluysian atrophy (DRPLA), and spinal and bulbar muscular atrophy (SBMA)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Neurodegenerative Diseases
Share to Mitochondrial Function and Pathology
Share to Neurogenetic and Muscular Disorders Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38996083
DOI: 10.1021/acschemneuro.4c00184

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polyglutamine (PolyQ) Diseases: Navigating the Landscape of NeurodegenerationPMID 38996083Read ↗

Polyglutamine (PolyQ) Diseases: Genetics to TreatmentsSemantic proximity Read ↗

The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies.Semantic proximity Read ↗

Juvenile Huntington’s Disease and Other PolyQ Diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic and Proteomic DataSemantic proximity Read ↗

Juvenile Huntington’s Disease and Other PolyQ diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic DataSemantic proximity Read ↗

Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense TherapiesSemantic proximity Read ↗

Polyglutamine Diseases: Where does Toxicity Come from? What is Toxicity? Where are We Going?Semantic proximity Read ↗

Toward an understanding of polyglutamine neurodegeneration.Semantic proximity Read ↗

Challenges of the Polyglutamine Diseases: From Dysfunctional Neuronal Circuitries to Neuron-Specific CAG Repeat InstabilitySemantic proximity Read ↗

Rare Neurodegenerative Diseases: Clinical and Genetic Update.Semantic proximity Read ↗

Polyglutamine expansion neurodegenerative diseaseSemantic proximity Read ↗

Mouse polyQ database: a new online resource for research using mouse models of neurodegenerative diseases.Semantic proximity Read ↗

Microsatellite expansions hidden within the human dark genome are translated in novel and toxic proteins causing muscle and neurodegenerative diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.